Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy using an anti-fucosyl-GM1 antibody and an anti-CD137 antibody

Combination therapy using an anti-fucosyl-GM1 antibody and an anti-CD137 antibody

US Patent 11104739 · Granted Aug 31, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Efflux pump-cancer antigen multi-specific antibodies and compositions, reagents,2025
Anti-CD47 antibody and use thereof2023
Anti-PD-L1 antibody and uses thereof2022
Anti-OX40 antibody and use thereof2022
Human monoclonal antibodies that bind CXCR4 and uses thereof2022
Anti-CD47 antibodies and uses thereof2022
Treatment of C1013G/CXCR4-associated Waldenstrom's macroglobulinemia with an ant2022
Interferon receptor 1 antibodies and their uses2021
Methods for inducing or enhancing an immune response by administering agonistic 2020
Monoclonal antibodies to programmed death 1 (PD-1)2019
Monoclonal antibodies to programmed death 1 (PD-1)2019
Treatment of hematologic malignancies with an anti-CXCR4 antibody2019